Chronic, ambulatory heart failure patients will be given ketone ester dietary supplementation
to determine therapeutic efficacy, metabolic adaptation, pharmacokinetics, associated
cognitive changes, and safety within this patient cohort in order to establish preliminary
data to later conduct a multi-center randomized clinical trial.